ROCK2 inhibition in kidney organoids that model ciliopathies, as well as in a patient-derived cystic cell and a mouse model that model PKD, suggest that preservation of tubule cell morphology and subsequent abrogation of cystic changes is a generalisable therapeutic strategy that could inhibit renal cyst initiation in the ciliopathy disease state. This evidence concerns the gene ROCK2 and ciliopathy.